Blue Note Therapeutics Product BNT 103 Usability and User Engagement

Blue Note Therapeutics

Status: Completed

Conditions: Breast Cancer Female

Treatments: Device: BNT103

Study type: Interventional

Funder types: Industry

Identifiers

NCT05032404

PROT002 - Test Plan 01 Rev A

Details and patient eligibility

About

This test aims to explore product development-focused usability and user engagement.

Full description

Sponsor is testing an innovative peer-to-peer communication tool during this trial.

Enrollment: 15 patients

Sex: Female

Ages: 35 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient can read, write, and speak in English
• Patient is between the ages of 35-55
• Diagnosed with Stage I-III breast cancer
• In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study
• Apple mobile phone or tablet user
• Willing to participate in study protocol

Exclusion criteria

• Any participant not meeting inclusion criteria

Trial design

Primary purpose: Device Feasibility

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

BNT103

Experimental group

Description:

All participants receive BNT103. BNT103 provides 10 sessions over approximately 10 weeks.

Treatment:

Device: BNT103